Effects of src-deficiency on the expression of in vivo toxicity of TCDD in a strain of c-src knockout mice procured through six generations of backcrossings to C57BL/6 mice

Toxicology

Volumn 172, Issue 2, 2002, Pages 125-141

  Dunlap, Debra Y ^a   Ikeda, Izumi ^a   Nagashima, Hitoshi ^a   Vogel, Christoph F A ^a   Matsumura, Fumio ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

c src Knockout mice; Differential toxicity; TCDD

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; GLYCOGEN; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); TRIACYLGLYCEROL;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACKCROSSING; BODY WEIGHT; CONTROLLED STUDY; DOWN REGULATION; FEMALE; KNOCKOUT MOUSE; LIVER WEIGHT; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; ONCOGENE SRC; PANCREAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WASTING SYNDROME; WEIGHT GAIN; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; BODY WEIGHT; DNA; ELECTROPHORESIS; FEMALE; GENES, SRC; INJECTIONS, INTRAPERITONEAL; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NADP; PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUBCELLULAR FRACTIONS; TETRACHLORODIBENZODIOXIN; TRIGLYCERIDES; WEIGHT GAIN;

EID: 0037139361     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(02)00006-9     Document Type: Article

References (36)

1. Characterization of receptors for recombinant tumor necrosis factor α from human placental membranes
2. Effect of in vivo administered 2,3,7,8-tetrachlorodibenzo-p-dioxin on DNA-binding activities of nuclear transcription factors in liver of guinea pigs
3. 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes elevation of the levels of the protein tyrosine kinase pp60src
4. Effect of TCDD on Ah receptor, ARNT, EGF and TGF-α expression in embryonic mouse urinary tract
5. The direct determination of liver triglycerides
6. C/EBPα: A critical regulator of genes governing integrative metabolic processes
7. Dose response relationship in mice following subchronic exposure to 2,3,5,8-tetrachlorodibenzo-p-dioxin: CYP1A1, CYP1A2, estrogen receptor and protein tyrosine phosphorylation
8. Accurate transcription initiation by DNA polymerase II in soluble extract from isolated mammalian nuclei
9. Differential toxicities of TCDD in vivo among normal, c-src knockout, geldanamycin and quercetin-treated mice
10. Significance of TCDD-induced changes in protein phosphorylation in the adipocyte of male guinea pigs
11. Evidence for a second pathway in the action mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Significance of Ah-receptor mediated activation of protein kinase under cell free conditions
12. Identification of c-src as the integral component of the Ah receptor complex transducing signals of 2,3,7,8-tetrachlorodibenzo-p-dioxin
13. Reciprocal regulation of adipogenesis by Myc and C/EBPα
14. The aryl hydrocarbon receptor complex
15. Biochemical mechanisms and cancer risk assessment models for dioxin
16. The action of 2,3,7,8-tetrachlorodibenzo-p-dioxin on transforming growth factor β 2 promoter activity are localized to the TATA box binding region and controlled through a tyrosine kinase-dependent pathway
17. Alteration by 2,3,7,8-tetrachlorodibenzo-p-dioxin of CCAAT/Enhancer binding protein correlates with suppression of adipocyte differentiation in 3T3-L1 cell
18. Suppression of C/EBPα and induction of C/EBPβ in mouse adipose tissue and liver
19. Acute 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure results in enhanced tyrosylphosphorylation and expression of murine hepatic cyclin dependent kinases
20. Effects of in vivo administered 2,3,7,8-tetrachlorodibenzo-p-dioxin on receptor binding of epidermal growth factor in the hepatic plasma membrane of rat, guinea pig, mouse and hamster
21. Commentary: How important is the protein phosphorylation pathway in the toxic expression of dioxin-type chemicals
22. Altered in vivo toxic expression of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in src-deficient mice
23. Is CCAAT/enhancer-binding protein a central regulator of energy metabolism
24. A comparison of three methods of glycogen measurements in tissues
25. Determination of phosphoenolpyruvate carboxykinase activity with deoxyguanosine 5′-diphosphatase nucleotide substrate
26. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: Examination of the mechanism of toxicity
27. TCDD reduces rat hepatic epidermal growth factor receptor: Comparison of binding, immunodetection, and autophosphorylation
28. Tumor-monitoring effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and phenobarbital in initiated weaning Sprague-Dawley rats: A quantitative, phenotypic and ras p21 study
29. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
30. TCDD causes stimulation of c-ras expression in the hepatic membranes in vivo and in vitro
31. Tissue specific effects of 2,3,7,8tetrachlorodibenzo-p-dioxin (TCDD) on the activity of phosphoenolpyruvate carboxykinase (PEPCK) in rats
32. Modulation of Prostaglandin H synthase-2 mRNA expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice
33. Regulation of prostaglandin endoperoxide 11 synthase 2 induction by dioxide in rat hepatocytes: Possible c-src mediated pathway
34. Correlation between toxicity and effects on intermediary metabolism in 2,3,7,8-tetrachlorodibenzo-p-dioxintreated male C57BL/6J and DBA/2J mice
35. Isolation and characterization of the mouse cytosolic for tissue-specific hypersensitive sites